Chondrial bags a $22M A round for mitochondrial R&D; Ariad filed marketing app for brigatinib
• Deerfield has taken the lead on a $22.6 million Series A for Chondrial Therapeutics, a Bala Cynwyd, PA-based biotech with a focus on rare …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.